» Articles » PMID: 39083791

Examining the Effectiveness of Electronic Patient-Reported Outcomes in People With Cancer: Systematic Review and Meta-Analysis

Overview
Publisher JMIR Publications
Date 2024 Jul 31
PMID 39083791
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Electronic patient-reported outcomes (ePROs) are commonly used in oncology clinical practice and have shown benefits for patients and health resource use.

Objective: The aim of this study was to compare the isolated effect of administering ePROs to patients with cancer versus a control condition.

Methods: The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed. Randomized controlled trials evaluating ePRO interventions that aimed to improve health-related outcomes among patients with cancer were included. The primary outcome was health-related quality of life (HRQOL), and the secondary outcomes were symptoms, hospital admissions, unplanned visits, chemotherapy completion, survival, and satisfaction with care. The effect sizes of ePROs on health-related outcomes were analyzed as standardized mean differences (SMDs) with 95% CIs using a random effects model.

Results: The search identified 10,965 papers, of which 19 (0.17%) from 15 studies were included. The meta-analysis showed an improvement in HRQOL at 3 months, measured by the Functional Assessment of Cancer Therapy–General (SMD 0.29, 95% CI 0.19 to 0.39), and at 6 months, assessed using various HRQOL measures (SMD 0.21, 95% CI 0.11 to 0.30). Of the 15 studies, 9 (60%) reported a positive signal on HRQOL, with two-thirds of the studies (n=6, 67%) including tailored patient advice and two-thirds (n=6, 67%) using clinician alert systems.

Conclusions: The meta-analysis showed an improvement in HRQOL at 6 months and in Functional Assessment of Cancer Therapy–General scores at 3 months for studies that included tailored advice and clinician alerts, suggesting that these elements may improve ePRO effectiveness. The findings will provide guidance for future use and help health care professionals choose the most suitable ePRO features for their patients.

Trial Registration: PROSPERO CRD42020175007; https://tinyurl.com/5cwmy3j6.

Citing Articles

Smartphone-based measures as real-world indicators of functional status in advanced cancer patients.

Straczkiewicz M, Keating N, Schonholz S, Matulonis U, Horowitz N, Campos S medRxiv. 2025; .

PMID: 39974129 PMC: 11838621. DOI: 10.1101/2025.02.04.25321686.


The Paradigm Shift From Patient to Health Consumer: 20 Years of Value Assessment in Health.

van den Broek-Altenburg E, Atherly A J Med Internet Res. 2025; 27:e60443.

PMID: 39793021 PMC: 11759916. DOI: 10.2196/60443.

References
1.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

2.
Yang J, Weng L, Chen Z, Cai H, Lin X, Hu Z . Development and Testing of a Mobile App for Pain Management Among Cancer Patients Discharged From Hospital Treatment: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019; 7(5):e12542. PMC: 6658226. DOI: 10.2196/12542. View

3.
Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M . Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009; 101(23):1624-32. PMC: 2786917. DOI: 10.1093/jnci/djp386. View

4.
Xu A, Wang Y, Wu X . Effectiveness of e-health based self-management to improve cancer-related fatigue, self-efficacy and quality of life in cancer patients: Systematic review and meta-analysis. J Adv Nurs. 2019; 75(12):3434-3447. DOI: 10.1111/jan.14197. View

5.
LeBlanc T, Abernethy A . Patient-reported outcomes in cancer care - hearing the patient voice at greater volume. Nat Rev Clin Oncol. 2017; 14(12):763-772. DOI: 10.1038/nrclinonc.2017.153. View